EFFICIENCY, SAFETY AND POSSIBILITIES OF IMMUNOTROPIC THERAPY AFTER SURGICAL TREATMENT OF ENDOMETRIOSIS
https://doi.org/10.21518/2079-701X-2018-13-50-56
Abstract
The identification of the immune system disorders along with the impact on the causative agent and correction of such disorders is of great importance in the therapy of patients with endometritis. It has been established that the infectious agents are eliminated by the phagocytic system cells, therefore the optimal choice for the activation of anti-infective immunity are the immunomodulators acting on the monocyte-macrophage system cells. Use of immunomodulators: recombinant human interleukin-2 (Roncoleukin®, IL-2) and Interferon alfa-2b + Taurine + Benzocaine (Genferon®) in combination with the standard therapy showed its safety and efficiency in treating patients with endometritis after caesarean section.
About the Authors
L. I. Anokhova
Chita State Medical Academy of the Ministry of Health of Russia
Russian Federation
Chita
Russian Federation
Chita
T. E. Belokrinitskaya
Chita State Medical Academy of the Ministry of Health of Russia
Russian Federation
Chita
Russian Federation
Chita
A. V. Pateyuk
Transbaikal State University
Russian Federation
Chita
Russian Federation
Chita
References
1. WHO recommendations for prevention and treatment of maternal peripartum infections. Guideline. World Health Organization, September 2015. 70 p. http://www.who.int/repmductivehealth/publications/maternaljperinatal health/peripartum-infections-guidelines/en/ (date of access 30.04.2018).
2. Veresova AA, Tyutyunik VL, Kan NE, Balushkin AA Modern ideas about the development of postpartum infectious and inflammatory complications. Voprosy ginekologii, akusherstva i perinatologii, 2013, 12(4): 30-37.
3. Adamyan LV, Artymuk NV, Belokrinitskaya TE, Gelfand BR, Kulikov AV, Protsenko DN et al. Septic complications in obstetrics. Clinical recommendations (protocol) of the ROAG and the Ministry of Health of the Russian Federation, Ministry of Health of the Russian Federation on February 6, 2017 No. 15-4 / 10 / 2-728. Moscow, 2017: 59 p.
4. Statement on maternal sepsis. World Health Organization, 2017. http://apps.who.int/iris/bitstream/10665/254608/1/WHO-RHR-17.02-eng. pdf (date of access 07.05.2018).
5. Snyder CC, Barton JR, Habli M, Sibai BM. Severe sepsis and septic shock in pregnancy: indications for delivery and maternal and perinatal outcomes. J Matern Fetal Neonatal Med. 2013 Mar, 26(5):503-6. DOI: 10.3109/14767058.2012.739221.
6. Say L, Chou D, Gemmill A, Tuncalp O, Moller A-B, Daniels J. Global causes of maternal death: a WHO systematic analysis. The Lancet Global Health, 2014, 2(6): 323-33.
7. Barinov SV, Medyannikova IV. Rogov EV Principles of prevention of obstetric complications associated with disturbances in the hemostatic system. Rossijskij vestnik akushera-ginekologa, 2014, 2: 77-81.
8. Kuznik BI Unconventional conceptions of mechanisms of thrombohemorrhagic syndrome and intravascular clotting. Tromboz, gemostaz i reologija, 2010, 1: 22-43
9. Belokrinitskaya ТЕ, Vitkovski YA Status protective systems and their correction at endometritis after childbirth andcaesarean section. Chita: Poisk, 1999. 114p.
10. Hofmeyr DY. Pregnancy and childbirth. Cochrane leadership. Moscow: Logosfera, 2010. 440 p.
11. Haitov RM, Pinegin BV. Immunomodulators: mechanism of action and clinical application. Immunologija, 2003, 4: 196-202.
12. Haitov RM, Alekseev LP. The regulatory role of the immune system in the body. Rossijskij fiziologicheskij zhurnal, 2010, 8: 787-805.
13. Makatsaria AD (ed.) Thrombohemorrhagic complications in obstetric practice: a guide for physicians. Moscow :MIA, 2011. 1056 p.
14. Gostev VV, Kalinogorskaya OS, Kruglov, AN, Sidorenko SV. Antibiotic resistance coagulase-negative staphylococci, selected in hospitals of St. Petersburg and Moscow. Antibiotiki i himioterapija, 2015, 60: 23-28.
15. Korobkov NA. Antibiotic resistance of gram-positive micrqflora isolatedfrom metroaspirate in parturient women with postpartum endometritis. Ural’skij medicinskij zhurnal, 2015, 3: 73-78.
16. Becker K, Heilmann C, Peters G. Coagulasenegative staphylococci. Clinical MicrobiolReviews, 2014, 27(4): 870-926.
17. Lang TA, Sesik M. How to describe statistics in medicine. M.: Prakticheskaja medicina. 2011. 480 p.
18. Ordzhonikidze NV, Yemelyanov AI Meshalkina IV. Postpartum infection. Moscow: Press-menu, 2012. 479 p.
19. Ordzhonikidze NV, Vanka LV, Matveeva NK, Meshalkina IV Prevention and comprehensive treatment of complications in parturient women with infectious risk. Lechenie i profilaktika, 2013, 2(6): 99-104.
20. Zubairov DM Modern evidence of the concept of continuous blood clotting in the body. Tromboz, gemostaz i reologija, 2010, 1: 17-21
21. Belotskii SM, Avtalion RR. Inflammation. Mobilization of cells and clinical effects. Moscow: BINOM, 2008. 240 p.
22. Momot АР, Taranenko IA, Tsyvkina LP The evolution of concepts about the thrombophilia and its role in the issues of human reproduction. Akusherstvo i ginekologija, 2013, 2: 4-9.
Review
For citations:
Anokhova LI, Belokrinitskaya TE, Pateyuk AV. EFFICIENCY, SAFETY AND POSSIBILITIES OF IMMUNOTROPIC THERAPY AFTER SURGICAL TREATMENT OF ENDOMETRIOSIS. Meditsinskiy sovet = Medical Council. 2018;(13):50-56. (In Russ.) https://doi.org/10.21518/2079-701X-2018-13-50-56
Views:
636
Email this article 